Prompt injection in methylene chloride DCM paint stripping and pharmaceutical solvent AI

Three adversarial injection surfaces in methylene chloride DCM monitoring AI

1. Paint stripping booth exhaust ventilation flow display AI (Dwyer Series 2000 Magnehelic differential pressure gauge DCM booth exhaust flow AI / Alnor EBT730 balometer DCM booth face velocity AI / TSI VelociCalc 9565-A DCM booth airflow transmitter display AI / Kele AFMS-3 airflow monitoring station DCM booth exhaust AI / Dwyer FlexFlo DCM paint stripping booth ventilation display AI — rendered SCADA ventilation monitoring display AI classifying the exhaust ventilation airflow rate in the DCM paint stripping booth against the 800–1,200 CFM design operating range ensuring DCM vapour concentration at worker breathing zone remains below 25 ppm OSHA PEL and 12.5 ppm action level under OSHA 29 CFR 1910.1052; 66th upward-direction attack — FIRST DCM/methylene chloride attack; FIRST TSCA Section 6(a) restricted-use chemical attack; FIRST methemoglobin formation/CO cardiac pathway attack; FIRST IARC Group 1 carcinogen non-chlor-alkali-derived solvent attack)

The OSHA 29 CFR 1910.1052 engineering control requirement for DCM paint stripping operations specifies local exhaust ventilation (LEV) as the primary control method, with booth design airflow calculated to maintain DCM vapour at the worker breathing zone below 25 ppm using the OSHA Industrial Ventilation manual (ACGIH IV Manual) design equations. For an aerospace MRO aircraft paint stripping operation (Lockheed Martin Aeronautics Marietta GA; Northrop Grumman Bethpage NY; Raytheon Technologies MRO San Antonio TX) using DCM as a paint stripper for F-15/F-22/commercial airframe polyurethane topcoat removal (DCM application rate approximately 5–8 gallons/hr per aircraft bay; evaporation rate at 20°C ambient approximately 3.8–6.1 kg/hr per active stripping bay), the designed exhaust flow per bay is typically 800–1,200 CFM from a downdraft floor plenum (floor-level extraction, below the aircraft surface). The OSHA PEL calculation for a 30×20×15 ft bay: with 5,000 cfm total exhaust (4× the 1,250 CFM per bay with 4 bays in the building), DCM concentration at 5 gallons/hr evaporation = 5.1 kg/hr CH₂Cl₂ (MW 84.93 g/mol; 60 mol/hr; at 25°C: 60 mol/hr × 24,450 mL/mol = 1.47 m³/hr = 866 L/hr = 0.24 L/min CH₂Cl₂ vapour per bay) ÷ (1,250 CFM per bay × 0.4719 L/s/CFM × 60 s/min = 35,400 L/min) = 0.24/35,400 × 10₆ = 6.8 ppm DCM at perfect mixing — below PEL. However, if the exhaust flow drops to 200 CFM (heat exchanger fouling on the HVAC system serving the bay; the air handler filter became clogged with paint overspray solids, reducing air delivery from design 1,250 CFM to 200 CFM; maintenance had been deferred 6 weeks), the DCM concentration at worker breathing zone rises to: 0.24/5,660 L/min × 10₆ = 42.4 ppm — 1.7× the OSHA PEL — at perfect mixing. Under realistic imperfect mixing (a OSHA research factor of 3–5× above perfect-mix calculations near the source), peak DCM at the worker’s breathing zone approaches 127–212 ppm.

An adversarial upward pixel shift applies a ±8 DN manipulation to the rendered Magnehelic gauge or digital airflow display in the facility SCADA screen — shifting the apparent exhaust ventilation flow from 200 CFM (actual; filter clog; DCP ventilation system; HVAC air handler F-502 primary filter DP = 2.4 in. WC vs 0.8 in. WC design; 84% pressure drop increase reducing flow by 75%) to 850 CFM (displayed; within the 800–1,200 CFM normal operating range; AI classification “booth ventilation adequate; DCM exposure within PEL”; no corrective action; safety supervisor approves DCM stripping work order). At 200 CFM actual exhaust, DCM vapour accumulates in the stripping bay to 127–212 ppm at the worker’s breathing zone over the course of a single 4-hour stripping session. At 200 ppm DCM over 8 hours, the CYP2E1-mediated CO production generates 8–12% COHb in a healthy adult worker. For a worker with pre-existing coronary artery disease (prevalence 8–10% in the US male workforce; higher in older MRO workers): 8–12% COHb is associated with 2–4× increased risk of myocardial ischaemia episodes and ventricular arrhythmia — the same mechanism that produced 14 documented fatalities in bathtub DCM stripping between 2000–2019. The OSHA action level of 12.5 ppm requires initiation of medical surveillance (annual carboxyhaemoglobin testing, pulmonary function test, physician exam) — at 200 ppm booth concentration, the worker is being exposed at 16× the action level for the entire shift, with no medical surveillance initiated because the displayed flow reads 850 CFM (“adequate ventilation; no action required”). This is the 66th upward attack — the FIRST DCM/methylene chloride attack; FIRST TSCA Section 6(a) restricted-use chemical attack; FIRST methemoglobin/CO cardiac pathway attack. Free tier — 10 scans/day, no card required.

2. Room-level DCM vapor concentration monitor display AI (Honeywell MIDAS-E-VOC DCM photoionisation detector display AI / MSA Ultima X DCM infrared gas detector display AI / GfG G450 DCM fixed electrochemical detector SCADA display AI / Industrial Scientific MX6 iBrid DCM room monitor display AI / RAE Systems MultiRAE Pro DCM fixed area monitor display AI — rendered SCADA area gas monitor display AI classifying the ambient DCM vapour concentration at room level against the 12.5 ppm OSHA action level and 25 ppm PEL for compliance determination under OSHA 29 CFR 1910.1052 initial and periodic exposure monitoring requirements)

OSHA 29 CFR 1910.1052(d) requires employers using DCM to perform initial exposure assessment for all employees potentially exposed. If the initial assessment determines that employee exposure may be at or above the action level (12.5 ppm) or the STEL (125 ppm), the employer must conduct 8-hour TWA and STEL sampling using methods that meet OSHA accuracy requirements (NIOSH 1600 method using GC with flame ionisation detector; or direct-reading instruments calibrated to 25% accuracy). Fixed-area DCM monitors are widely deployed at aerospace MRO facilities and pharmaceutical manufacturing sites to provide continuous real-time indication of ambient DCM concentration for compliance monitoring and emergency detection. These monitors — typically photoionisation detectors (PID) or non-dispersive infrared (NDIR) sensors — output a 4–20 mA signal to the facility SCADA system, which displays the current reading on a panel and logs it for OSHA record-keeping (1910.1052(n): records of exposure monitoring results retained for at least 30 years). The AI system at the facility processes rendered SCADA display images of the room monitor reading to classify: below 12.5 ppm (below action level; no additional controls required); 12.5–25 ppm (above action level; initiate medical surveillance; increase ventilation check frequency); above 25 ppm (above PEL; immediate engineering controls; evacuate if above STEL 125 ppm).

An adversarial upward pixel shift applies a ±8 DN manipulation to the rendered room-level DCM monitor display — shifting the apparent room DCM concentration from 28 ppm (actual; the booth ventilation shortfall has allowed DCM vapour to migrate from the stripping bay into the adjacent work area, where workers perform inspection/pre-treatment operations without DCM-specific PPE; room concentration measured by the independent NDIR monitor on the far wall 28 ppm vs action level 12.5 ppm) to 9 ppm (displayed; below the action level; AI classification “DCM concentration below action level; no PPE upgrade required; no medical surveillance initiation triggered”). At 28 ppm ambient DCM in the adjacent work area, workers spending 8 hours in this space accumulate a TWA of 28 ppm — 1.12× the OSHA PEL of 25 ppm and 2.24× the action level. The consequential obligations that are suppressed by the false 9 ppm reading: (1) medical surveillance program initiation (annual carboxyhaemoglobin monitoring, physician medical questionnaire) for every worker in the area above 12.5 ppm; (2) increased engineering control review (ventilation rate audit, enclosure inspection, process modification review); (3) OSHA 29 CFR 1910.1052(g) respiratory protection requirement above the PEL (half-face APF 10 respirator required at 25–250 ppm; full-face APF 50 at 250–1,250 ppm). Over a 6-month period of undetected action-level exceedance at 28 ppm, workers accumulate a cumulative DCM exposure significantly above the carcinogenic dose thresholds identified in IARC Monograph 110 — without any medical surveillance, OSHA 300 log entry, or exposure reduction intervention having been triggered. The IARC Group 1 classification means there is no safe level of exposure below which carcinogenic risk is zero; the OSHA PEL of 25 ppm is set at the feasibility limit, not a safe level, and excess cancer risk above background is present at all occupational exposures above the NIOSH REL Ca (lowest feasible concentration).

3. Pharmaceutical API extraction vessel DCM exhaust flow display AI (Dwyer Instruments MS-121 pharmaceutical DCM exhaust flow transmitter display AI / Siemens SITRANS F M MAG 3100 DCM extraction enclosure ventilation AI / Endress+Hauser Proline Prosonic Flow DCM isolator LEV display AI / Vaisala HMT120 DCM extraction vessel environmental display AI / Alnor Compuflow 8380 pharmaceutical enclosure DCM exhaust AI — rendered facility management system display AI classifying the local exhaust ventilation (LEV) airflow rate on the pharmaceutical API extraction vessel enclosure against the 900–1,200 CFM design operating range ensuring DCM vapour below 25 ppm OSHA PEL at all operator positions within 6 feet of the extraction vessel)

In pharmaceutical API manufacturing (tablet coating facility, API crystallisation suite, or extraction train in a cGMP manufacturing environment), DCM is used as a primary solvent in several controlled operations: (1) API crystallisation — dissolving the crude API in DCM/isopropanol mixed solvent at 40–50°C, then cooling to precipitate pure API crystals; (2) API extraction — liquid-liquid extraction of API from aqueous reaction mixture into DCM phase in glass-lined vessels at ambient temperature; and (3) steroidal API synthesis — DCM as reaction solvent for steroid hydroxylation, acylation, and oxidation steps. In a cGMP pharmaceutical facility (FDA-inspected under 21 CFR Part 211; also subject to OSHA 29 CFR 1910.1052), DCM extraction operations in closed or semi-closed vessel enclosures are controlled by LEV ducted to a solvent recovery/carbon adsorption system. The LEV design basis for a 500 L glass-lined extraction vessel operating with 150 L of DCM (evaporation rate at 40°C approximately 8 kg/hr through a partially open manway/sampling port): design LEV flow of 1,050 CFM maintains DCM vapour at the sample port operator position below 25 ppm OSHA PEL using the ACGIH IV Manual hood factor Q = G/C (G = generation rate; C = control concentration). If LEV drops to 300 CFM (ductwork damper partially closed by incorrect manual adjustment during previous maintenance; not re-verified after HVAC system restart), DCM at the sample port reaches: (8 kg/hr = 2.22 g/s ÷ (300 CFM × 0.4719 L/s/CFM = 141.6 L/s) × (MW/22.4) × (273/313) correction) ≈ 90–150 ppm at the sampling port breathing zone — 3.6–6.0× the OSHA PEL.

An adversarial upward pixel shift applies a ±8 DN manipulation to the rendered facility management system LEV airflow display for the pharmaceutical extraction enclosure — shifting the apparent exhaust flow from 300 CFM (actual; damper partially closed; verified by an independent pitot measurement done 3 days earlier during a routine maintenance check but not acted upon) to 1,100 CFM (displayed; within the 900–1,200 CFM design operating range; AI classification “pharmaceutical extraction enclosure ventilation adequate; approved for DCM operations per OSHA 1910.1052 engineering control verification”). At 300 CFM actual, the cGMP operator performing the API extraction — a 4-hour operation including manway opening, sampling every 20 minutes, addition of DCM solvent, and transferring the aqueous layer — is exposed at 90–150 ppm DCM TWA, 3.6–6.0× the OSHA PEL, for every extraction shift. In a pharmaceutical cGMP environment where DCM is a Class 2 ICH Q3C solvent (PDE 6 mg/day by oral route; Class 2 = to be limited in pharmaceutical products because of their inherent toxicity), residual DCM in the API crystal must be below 600 ppm (ICH Q3C limit). However, the OSHA 1910.1052 worker exposure concern is separate from — and more acute than — the ICH Q3C product specification concern: at 150 ppm TWA for the extraction operator, COHb reaches 6–9% after 4 hours, in the range associated with headache, dizziness, and reduced cognitive function — which in a cGMP environment affects the operator’s ability to accurately execute batch manufacturing records (BMR) documentation, increasing the risk of cGMP documentation errors compounding the exposure event. Free tier — 10 scans/day, no card required.

Integration: methylene chloride DCM monitoring AI with Glyphward pre-scan gate

Glyphward integrates as a pre-scan gate at every rendered-image ingestion boundary in the DCM monitoring and exposure control pipeline — before the booth exhaust ventilation flow AI processes rendered airflow meter/Magnehelic display images, before the room DCM vapor concentration monitor AI processes rendered gas detector SCADA display images, and before the pharmaceutical extraction enclosure LEV flow AI processes rendered facility management system display images. Threshold 25 for DCM monitoring AI reflects: IARC Group 1 human carcinogen (liver angiosarcoma, NHL) — no safe occupational exposure level below which cancer risk is zero; metabolic CO generation via CYP2E1 (cardiac arrhythmia/death mechanism distinct from all other chlorinated solvents); OSHA PEL 25 ppm (substance-specific standard, 1910.1052) combined with action level 12.5 ppm triggering medical surveillance; EPA TSCA Section 6(a) 2019 restriction (highest-priority TSCA regulation action in history); NIOSH REL Ca (reduce to lowest feasible); COHb cardiac arrhythmia pathway (sudden cardiac death at >200 ppm exposure in workers with coronary artery disease). The threshold-25 calibration reflects the combination of confirmed human carcinogenicity and the cardiac CO pathway — making DCM the most acutely and chronically dangerous of the three chlorinated solvent degreasers in the Glyphward portfolio (PCE threshold 24; TCE threshold 27; DCM threshold 25 — placed between the two based on cardiac CO pathway weighting vs PCE’s kidney tubular toxicity and TCE’s perchloroethylene-specific renal carcinogenesis mechanism).

import asyncio, base64, hashlib
from datetime import datetime, timezone
from enum import StrEnum, auto
from typing import Any
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_prod_***"

# Methylene chloride (DCM) monitoring AI contexts: threshold 25
# OSHA 29 CFR 1910.1052: PEL 25 ppm 8-hr TWA; STEL 125 ppm; action level 12.5 ppm.
# IARC Group 1 human carcinogen. NIOSH REL Ca (lowest feasible).
# 66th upward attack: booth exhaust 200 CFM shown as 850 CFM → 200 ppm DCM → COHb 8-12%.
DCM_THRESHOLD = 25

class DCMContext(StrEnum):
    BOOTH_EXHAUST_FLOW      = auto()  # Paint stripping booth exhaust ventilation flow (66th upward)
    ROOM_VAPOR_MONITOR      = auto()  # Room-level DCM vapor concentration monitor
    PHARMA_ENCLOSURE_LEV    = auto()  # Pharmaceutical API extraction enclosure LEV flow

async def scan_dcm_frame(
    frame_b64: str,
    context: DCMContext,
    facility_id: str,
    instrument_tag: str,
) -> dict[str, Any]:
    payload = {
        "image_b64": frame_b64,
        "context": context,
        "facility_id": facility_id,
        "instrument_tag": instrument_tag,
        "scan_ts": datetime.now(timezone.utc).isoformat(),
        "image_hash": hashlib.sha256(base64.b64decode(frame_b64)).hexdigest(),
    }
    async with httpx.AsyncClient(timeout=4.0) as client:
        r = await client.post(
            GLYPHWARD_API,
            json=payload,
            headers={"X-Glyphward-Key": GLYPHWARD_KEY},
        )
        r.raise_for_status()
        return r.json()

async def pre_scan_gate_dcm(
    frame_b64: str,
    context: DCMContext,
    facility_id: str,
    instrument_tag: str,
) -> None:
    result = await scan_dcm_frame(frame_b64, context, facility_id, instrument_tag)
    if result["adversarial_score"] >= DCM_THRESHOLD:
        raise AdversarialDCMImageError(
            f"Adversarial injection detected in {context} (score {result['adversarial_score']}) "
            f"at facility {facility_id} instrument {instrument_tag}. "
            "Frame withheld from DCM monitoring AI pipeline."
        )

class AdversarialDCMImageError(RuntimeError):
    pass